FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication

Key TakeawaysThe U.S. Food and Drug Administration has updated its recall of a common thyroid medication to Class IIThe recall is due to subpotent active ingredients It affects roughly 160,630 bottles of levothyroxine sodium tablets .THURSDAY, July 24, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has upgraded a recall of a commonly prescribed thyroid medication due to what it described as "subpotent" active ingredients.The recall of more than 160,000 bottles of levothyroxine sodium, which went into effect June 20, was upgraded to a Class II recall on July 23. Class II recalls occur when use of the drug poses a moderate public health risk, according to the FDA.The recall was initiated because the medication content of the recalled pills is “below the approved specification,” according to the New York-based television network NTD.No other details were available about the recall, including whether anyone has become ill from the weak pills.Levothyroxine sodium is used to treat a sluggish thyroid gland (hypothyroidism). Left untreated, hypothyroidism can lead to heart problems and high cholesterol, among other issues, according to the Mayo Clinic.The recalled drugs are manufactured by India-based Intas Pharmaceuticals for North Carolina-based Accord Healthcare, NTD reported. They total 160,630 bottles and come in various doses, strengths, and packages, including:Lot D2400536; expiration date, Feb. 28, 2026Lot D2300325; expiration date, Jan. 31, 2026Lot D2400679; expiration date, Feb. 28, 2026Lot D2300087; expiration date, Dec. 31, 2025Lot D2300092; expiration date, Dec. 31, 2025Lot D2400722; expiration date, March 31, 2026Lot D2300104; expiration date, Dec. 31, 2025Lot D2300076; expiration date, Dec. 31, 2025Lot D2300042; expiration date, Dec. 31, 2025More informationMore details on the recalled thyroid pills can be found on the FDA’s website.SOURCES: U.S. Food and Drug Administration, alert, July 23, 2025; NTD, July 23, 2025.What This Means For YouPeople taking levothyroxine sodium should check the lot number on their medication against the recall list and seek their doctor's advice if it is a match..Sign up for our weekly HealthDay newsletter

FDA Upgrades Recall on 160,000+ Bottles of Thyroid Medication

Related Stories

More Than Four in 10 Adults Not Up to Date on Measles Vaccine

One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says

Cough Drops From Several Brands Being Recalled, FDA Says

Pizza Recall Issued in 10 States Over Metal Risk